|
PROK | Prokidney Corp. |
|
|
PROK | Prokidney Corp. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 0.67 |
| Leverage | 10.51% |
| Market Cap | $ 334.3m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -84.0m |
| Margin | -10293.64% |
ProKidney Corporation. The company is headquartered in Winston-Salem, North Carolina.